Hypertension as a predictor of adverse cardiac events in patients with borderline fractional flow reserve.
OBJECTIVE
The cut-off value myocardial fractional flow reserve (FFRmyo) < 0.75 identifies patients with clinically significant coronary stenosis. Normally PCI is deferred with a FFRmyo > or = 0.75. Other clinical characteristics may affect such treatment decision. Therefore, we studied the association between baseline characteristics and clinical outcomes in an unselected patient cohort with coronary artery disease, with intermediate coronary stenosis, initially referred for PCI, but in whom the intervention was deferred on the basis of FFRmyo > or = 0.75.


METHODS
Angiographic analysis and follow-up were performed in 152 patients with stable or unstable angina pectoris with intermediate coronary stenosis severity and normal left ventricular function. A major adverse cardiac event (MACE) was defined as postprocedural acute myocardial infarction (AMI), target vessel revascularization (TVR) and verified cardiac death.


RESULTS
More adverse cardiac events occurred in patients with 0.75 < or = FFRmyo < 0.80 (24/30) compared with FFRmyo > or = 0.80 (9/97) (P < 0.001). Hypertension, diabetes and hyperlipidaemia were significantly associated with the occurrence of MACE in the univariate analyses. Logistic regression analyses showed that only hypertension remained as a significant independent predictor of MACE for patients with 0.75 < or = FFRmyo < 0.80 (P < 0.10).


CONCLUSIONS
In an unselected patient population with coronary artery disease, a FFRmyo cut-off value of 0.8 should be used in hypertensive patients to discriminate between clinically significant coronary stenosis.
Arslan
Fatih
F
Heart Lung Center Utrecht, Department of Cardiology at the University Medical Center Utrecht, Utrecht, The Netherlands. f.arslan@umcutrecht.nl
Kaya
Mehmet G
MG
van der Heijden
Geert
G
Timurkaynak
Timur
T
Cengel
Atiye
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000787:Angina Pectoris / Q000150:complications / Q000503:physiopathology; D015906:Angioplasty, Balloon, Coronary; D006328:Cardiac Catheterization; D017023:Coronary Angiography; D023921:Coronary Stenosis / Q000150:complications* / Q000000981:diagnostic imaging / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D053805:Fractional Flow Reserve, Myocardial; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology* / Q000401:mortality / Q000503:physiopathology*; D011237:Predictive Value of Tests; D012107:Research Design; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014421:Turkey